ecrin-mdr-crcClinical2009Metastatic Colorectal CancerColon CancerColorectal NeoplasmsMetastatic Colorectal CancerColon CancerColorectal NeoplasmsInterventionalhttps://newmdr.ecrin.org/Study/2070218United States5CRCApo2L/TRAILAvastinBevacizumabECRIN MDRCompletedfalseA Study of Dulanermin Administered in Combination With the FOLFOX Regimen and Bevacizumab in Patients With Previously Untreated, Locally Advanced, Recurrent, or Metastatic Colorectal CancerThis is a multicenter, open-label study enrolling a total of up to 23 patients.2009-05-152070218NCT00873756